Biohit Oyj (HEL:BIOBV)

Finland flag Finland · Delayed Price · Currency is EUR
2.330
+0.020 (0.87%)
May 18, 2026, 6:29 PM EET
Market Cap35.12M -14.3%
Revenue (ttm)15.73M +10.1%
Net Income2.74M +6.6%
EPS0.18 +6.3%
Shares Out15.21M
PE Ratio12.83
Forward PE15.40
Dividendn/a
Ex-Dividend Daten/a
Volume1,665
Average Volume9,801
Open2.320
Previous Close2.310
Day's Range2.320 - 2.390
52-Week Range2.200 - 3.780
Beta0.56
RSI40.83
Earnings DateAug 5, 2026

About Biohit Oyj

Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide. The company offers GastroPanel quick test NT, a rapid and quantitative immunochromatographic test for the detection of Helicobacter pylori and atrophic gastritis; GastroPanel test, a blood test for diagnosis of the function and structure of stomach mucosa; GastroSoft, a software application designed to assist clinicians and general practi... [Read more]

Sector Healthcare
Founded 1988
Employees 46
Stock Exchange Nasdaq Helsinki
Ticker Symbol BIOBV
Full Company Profile

Financial Performance

In 2025, Biohit Oyj's revenue was 15.73 million, an increase of 10.14% compared to the previous year's 14.28 million. Earnings were 2.74 million, an increase of 6.62%.

Financial Statements